LOGIN
RCT
ACE Report #12324
Corticosteroid Injection Addition to Casting is Superior to Casting Alone for De Quervain's Disease
How to Cite
OrthoEvidence. Corticosteroid Injection Addition to Casting is Superior to Casting Alone for De Quervain's Disease. ACE Report. 2020;9(9):16. Available from: https://myorthoevidence.com/AceReport/Report/12324
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Methylprednisolone acetate injection with casting versus casting alone for the treatment of De-Quervain's Tenosynovitis: a randomized controlled trial.
J Pak Med Assoc. 2020 Aug;70(8):1314-1318.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
One hundred and seventy-four patients with De Quervain's tenosynovitis were randomized to receive a thumb Spica cast and a corticosteroid injection (1mL of 10 mg) of triamcinolone acetonide and (1mL) lidocaine, or a thumb Spica cast alone to evaluate improvement in pain and function. The primary outcomes of interest included pain on a Visual Analog Scale (VAS) and the Quick Disability of the Arm, ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.
LEARN MOREFor Reprints and Permissions, click here
Please Login or Join to leave comments.